Related Experiment Video
Updated: Aug 5, 2026

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker
Published on: September 15, 2023
High expression of the multifunctional proto-oncogene BMI1 predicts poor outcome in high-grade serous carcinoma
Pia Roering1, Lilla Csellar2, Sami Blom3
1Department of Pathology, Institute of Biomedicine and FICAN West Cancer Centre, Faculty of Medicine, University of Turku, Turku, Finland; Turku Doctoral Program of Molecular Medicine (TuDMM), Faculty of Medicine, University of Turku, Turku, Finland; Department of Pathology, Lapland Central Hospital, Rovaniemi, Finland.
Objective:
Tubo-ovarian high-grade serous carcinoma (HGSC) has a poor prognosis due to limited treatment options, therapy resistance, and high recurrence rates. One proposed mechanism underlying treatment failure is the survival of cancer stem cells (CSCs) following chemotherapy. In previous in vitro studies, we identified ALDH1A1, SOX2, MYC, and BMI1 as putative CSC markers, with increased expression linked to platinum resistance. This study aimed to evaluate the expression and prognostic relevance of these four markers in diagnostic, treatment-naïve HGSC tissue specimens.
Methods:
We performed immunohistochemistry (IHC) on adnexal and extrapelvic samples from patients with stage III-IV HGSC. The expression levels of ALDH1A1, SOX2, MYC and BMI1 were manually scored and correlated with clinical parameters, including platinum-free interval (PFI) and overall survival (OS). Significant findings were validated with RNA in situ hybridization scoring, using an AI-assisted image analysis tool developed in this project.
Results:
We found that all four proteins are widely expressed across tumor samples. High MYC and high BMI1 protein expression are each significantly associated with reduced PFI and OS. Higher expression levels are noted in extrapelvic tumor sites as compared to adnexal. In multivariable analysis, BMI1 expression remains an independent predictor of poor outcome. The significance of BMI1 as a prognostic marker is further demonstrated by RNA-ISH analysis, again showing independent association with outcome.
Conclusions:
Our findings highlight BMI1 as a clinically applicable prognostic marker in HGSC and suggests its potential as a therapeutic target.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...